Beta-blocker interruption or continuation after myocardial infarction? a systematic review and meta-analysis

Back

ESC2025 Premium Access

Beta-blocker interruption or continuation after myocardial infarction? a systematic review and meta-analysis

Session: Pharmacotherapy in acute coronary syndromes (2)

Topic: Treatment

Speaker: Doctor C. Fischer Bacca (Rio do Sul, BR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Caroline Fischer Bacca

University Center for the Development of Alto Vale - UNIDAVI, Rio do Sul (Brazil)

2 presentations

0 follower

5 more presentations in this session

Aspirin does not not associate with lower risk of major cardiovascular events or increased risk of bleeding in older individuals undergoing cardiac computed tomography angiography

Speaker: Mr N. Kromann Noehr (Aalborg, DK)

Breathing patterns and ventilator efficiency in patients with acute coronary syndrome receiving ticagrelor - an analysis of the Bern Rehab Registry

Speaker: Doctor A. Von Hardenberg (Bern, CH)

Access

Abstract

Slides

Colchicine in acute coronary syndrome: an updated meta-analysis of randomized controlled trials

Speaker: Doctor K. Hosseini (Tehran, IR)

Clinical outcomes after stent thrombosis in patients with hemodialysis: from the Real-ST registry

Speaker: Doctor Y. Kakimoto (Saga, JP)

Intravenous nicorandil during primary percutaneous coronary intervention for acute myocardial infarction

Speaker: Doctor J. Ge (Shanghai, CN)

Access

Slides

Access the full session

Pharmacotherapy in acute coronary syndromes (2)

Speakers: Doctor C. Fischer Bacca, Mr N. Kromann Noehr, Doctor A. Von Hardenberg, Doctor K. Hosseini, Doctor Y. Kakimoto...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources